Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line.

DonateNow
Print this article

Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line.

Blood. 1998 Jan 1;91(1):258-65. Unique Identifier : AIDSLINE MED/98077538
Biswas P; Delfanti F; Bernasconi S; Mengozzi M; Cota M; Polentarutti N; Mantovani A; Lazzarin A; Sozzani S; Poli G; AIDS Immunopathogenesis Unit, DIBIT, and the Division of Infectious; Diseases, San Raffaele Scientific Institute, Milan, Italy.


Abstract: Induction of chemokine gene expression from peripheral blood mononuclear cells (PBMCs) stimulated by proinflammatory cytokines plays an important role in both wound repair and response to infectious agents. In the present study, we show that the proinflammatory cytokine interleukin-6 (IL-6) potently induced mRNA expression and secretion of the CC chemokine monocyte chemotactic protein 1 (MCP-1) in PBMCs. In addition, because human immunodeficiency virus (HIV) infection in vivo and in vitro has been shown to dysregulate the production of and/or the response to cytokines, PBMCs from both healthy uninfected and HIV-infected individuals were studied for their constitutive and IL-6-induced expression of MCP-1. No substantial differences were observed between the two groups of individuals. In addition, IL-6 upregulated MCP-1 expression in the promonocytic cell line U937 and in its chronically HIV-infected counterpart, U1. In these cell lines, IL-6 selectively induced MCP-1 and not other chemokines, including regulated upon activation normal T cells expressed and secreted (RANTES), macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and IL-8. IL-6 induction of MCP-1 was partially inhibited by hydrocortisone in U1 cells. Thus, IL-6 activates PBMCs to secrete MCP-1, a CC chemokine pivotal for monocyte recruitment in tissue and organs in which important inflammatory events occur.
Keywords: *Gene Expression Regulation/DRUG EFFECTS *Interleukin-6/PHARMACOLOGY *Leukocytes, Mononuclear/DRUG EFFECTS *Lymphoma, Large-Cell, Diffuse/PATHOLOGY *Monocyte Chemoattractant Protein-1/BIOSYNTHESIS *Monocytes/DRUG EFFECTS *Neoplasm Proteins/BIOSYNTHESIS *Tumor Stem Cells/DRUG EFFECTSKWDgeneexpressionregulation/drugeffectsKWDinterleukin-6/pharmacologyKWDleukocytes,mononuclear/drugeffectsKWDlymphoma,large-cell,diffuse/pathologyKWDmonocytechemoattractantprotein-1/biosynthesisKWDmonocytes/drugeffectsKWDneoplasmproteins/biosynthesisKWDtumorstemcells/drugeffects
980430
M9841828

ÆGIS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

ÆGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on ÆGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ÆGiS, or the party credited as the provider of the content.